PQ 166
168 Deputy Billy Kelleher asked the Minister for Health the reason the Health Service Executive has not yet approved reimbursement of the drug gilenya; his views on whether the drug provides life-changing benefits for MS patients; the reason there has been a lack of adherence to the criteria and timescales surrounding the reimbursement process; and if he will make a statement on the matter. [28778/12]
Introduced
14 June 2012
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
14 June 2012
Summary
168 Deputy Billy Kelleher asked the Minister for Health the reason the Health Service Executive has not yet approved reimbursement of the drug gilenya; his views on whether the drug provides life-changing benefits for MS patients; the reason there has been a lack of adherence to the criteria and timescales surrounding the reimbursement process; and if he will make a statement on the matter. [28778/12]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 14 June 2012
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2012-06-14/166/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2012-06-14/pq_166